Eli Lilly & Co. vs United Therapeutics Corp
LLY vs UTHR — side-by-side comparison from reported financials. LLY leads 7, UTHR leads 4 of 11 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
United Therapeutics Corp
UTHR · Healthcare
$549.16+3.07%Strong
| Metric | LLY | UTHR |
|---|---|---|
| Price | $1 177.20 | $549.16 |
| Market cap | $1.05T | $23.6B |
| Revenue (TTM) | $79.7B | $3.15B |
| Revenue growth | +31.7% | +18.0% |
| Net margin | 33.5% | 41.6% |
| Free cash flow | $18.2B | $1.09B |
| Net cash (debt) | ($35.2B) | $2.88B |
| 1-year price return | +37.6% | +23.3% |
| P/E | 41.6 | 18.0 |
| P/E vs own history (cheap-side %) | 88% | 26% |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | 20% |
| Altman Z-score | 7.10 | 21.46 |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 50,000 | 1,400 |
Full résumé-style profiles: LLY CV · UTHR CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.